https://www.selleckchem.com/B-Raf.html
However, only two studies provided the data of responders, and the result failed to figure out a significant difference (Z = 0.75, P = 0.45, 95% CI (odds ratio) 1.47 (0.54-4.02); I2 = 61%). It is difficult to define whether tVNS improved QOL between treatment and control groups using the available data. The adverse effects seem to be very few, with the most common being headache. CONCLUSION tVNS is an effective procedure to control the frequency of seizures according to the available data, especially for those patients who do not want to tolerate
Like
Comment
Share
